SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000932440-16-000336
Filing Date
2016-02-16
Accepted
2016-02-16 16:12:33
Documents
1
Group Members
RIDGEBACK CAPITAL INVESTMENTS LTDRIDGEBACK CAPITAL MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A sch13g-a_4252365.htm SC 13G/A 99894
  Complete submission text file 0000932440-16-000336.txt   101560
Mailing Address ONE PARROTT DRIVE SHELTON CT 06484
Business Address ONE PARROTT DRIVE SHELTON CT 06484 203-567-1500
Cara Therapeutics, Inc. (Subject) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87880 | Film No.: 161428283
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 NINTH AVENUE 5TH FLOOR NEW YORK NY 10011
Business Address 75 NINTH AVENUE 5TH FLOOR NEW YORK NY 10011 212-808-7729
Ridgeback Capital Investments L.P. (Filed by) CIK: 0001423994 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A